Edit |   |
---|---|
Product Name | GBR-12909 2HCl |
Description | GBR-12909 2HCl is a small molecule which can act as a Dopamine reuptake inhibitor. It is provided as a powder. This product acts on the following target types: Dopamine, ER/Golgi. This product acts on the following biochemical pathways: Calcium signaling. This product may be of interest in the following research areas and diseases: Neuroscience, Mood disorders. This product may act as a Coronavirus inhibitor: Sigma receptor agonist (SARS-CoV-2 Nsp6 protein interacts with the Sigma receptor). Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 523.50 g/mol |
Size | 10 mg, 50 mg |
Concentration | n/a |
Applications | n/a |
Other Names | GBR-12909 2HCl, 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride, Vanoxerine, 67469-78-7 |
Gene, Accession, CAS # | CAS: 67469-78-7 |
Catalog # | abx282345 |
Price | please inquire |
Order / More Info | GBR-12909 2HCl from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950